Security · CUSIP 803607AD2
SAREPTA THERAPEUTICS INC
NOTE 1.250% 9/1 · institutional ownership from 13F filings
Q3 2026 is still being filed (deadline 45 days after quarter end), so holder counts are incomplete.
13F holders
6
Shares held
1.8M
Value held
$1.7M
New / sold out
2 / 0
Added / reduced
0 / 1
net +132.0K shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q3 2026
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| FINANCIAL CONSULATE, INC | 1,047,000 | $999.3K | 0.11% |
| HB Wealth Management, LLC | 555,000 | $529.5K | 0.00% |
| HARBOR INVESTMENT ADVISORY, LLC | 100,000 | $96.0K | 0.01% |
| Capital Investment Advisory Services, LLC | 37,000 | $35.5K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 21,000 | $20.0K | 0.00% |
| Greenspring Advisors, LLC | 14,000 | $13.4K | 0.00% |
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| HARBOR INVESTMENT ADVISORY, LLC | New | +100,000 | – |
| Capital Investment Advisory Services, LLC | New | +37,000 | – |
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | Reduced | -5,000 | -19.2% |